[1]
R. Bapir, “Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis”, Arch Ital Urol Androl, vol. 95, no. 2, Jun. 2023.